[{"Assets_0_FY_USD":1537349000.0,"EarningsPerShareDiluted_4_FY_USD":4.26,"EarningsPerShareDiluted_1_FY_USD":0.98,"EarningsPerShareBasic_4_FY_USD":4.34,"EarningsPerShareBasic_1_FY_USD":0.99,"StockholdersEquityConverted_0_FY_USD":-9233000.0,"StockholdersEquity_0_FY_USD":-9513000.0,"RevenuesConverted_1_FY_USD":549386000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":86864000.0,"NetIncomeLossConverted_4_FY_USD":377031000.0,"NetIncomeLossConverted_1_FY_USD":85638000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":400084000.0,"CommonStockSharesOutstanding_0_FY_shares":86100000.0,"CommonStockSharesConverted_0_FY_shares":105087000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":88470000.0,"RevenuesConverted_4_FY_USD":2213242000.0,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-K","period":"20181231","fy":"2018.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20190215"}]